Skip to main content
Top
Published in:

16-12-2024 | Letter to the Editor

Comment on “SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect”

Authors: Rose Peronard, Stephan Mayntz

Published in: American Journal of Cardiovascular Drugs | Issue 1/2025

Login to get access

Excerpt

We read with great interest the review by Aristizábal-Colorado et al., which explores the diverse mechanisms underlying the cardioprotective and renoprotective effects of SGLT2 inhibitors [1]. While the review explores metabolic, hemodynamic, and anti-inflammatory effects, we would like to highlight certain gaps and potential oversights that warrant further discussion. …
Literature
3.
go back to reference Khouri C, Cracowski JL, Roustit M. SGLT-2 inhibitors and the risk of lower-limb amputation: is this a class effect? Diabetes Obes Metab. 2018;20(6):1531–4.CrossRefPubMed Khouri C, Cracowski JL, Roustit M. SGLT-2 inhibitors and the risk of lower-limb amputation: is this a class effect? Diabetes Obes Metab. 2018;20(6):1531–4.CrossRefPubMed
5.
go back to reference Li X, Hoogenveen R, El Alili M, Knies S, Wang J, Beulens JWJ, et al. Cost-effectiveness of SGLT2 inhibitors in a real-world population: a MICADO model-based analysis using routine data from a GP registry. Pharmacoeconomics. 2023;41(10):1249–62.CrossRefPubMedPubMedCentral Li X, Hoogenveen R, El Alili M, Knies S, Wang J, Beulens JWJ, et al. Cost-effectiveness of SGLT2 inhibitors in a real-world population: a MICADO model-based analysis using routine data from a GP registry. Pharmacoeconomics. 2023;41(10):1249–62.CrossRefPubMedPubMedCentral
6.
go back to reference Seidu S, Alabraba V, Davies S, Newland-Jones P, Fernando K, Bain SC, et al. SGLT2 Inhibitors—the new standard of care for cardiovascular, renal and metabolic protection in type 2 diabetes: a narrative review. Diabetes Ther. 2024;15(5):1099–124.CrossRefPubMedPubMedCentral Seidu S, Alabraba V, Davies S, Newland-Jones P, Fernando K, Bain SC, et al. SGLT2 Inhibitors—the new standard of care for cardiovascular, renal and metabolic protection in type 2 diabetes: a narrative review. Diabetes Ther. 2024;15(5):1099–124.CrossRefPubMedPubMedCentral
Metadata
Title
Comment on “SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect”
Authors
Rose Peronard
Stephan Mayntz
Publication date
16-12-2024
Publisher
Springer International Publishing
Published in
American Journal of Cardiovascular Drugs / Issue 1/2025
Print ISSN: 1175-3277
Electronic ISSN: 1179-187X
DOI
https://doi.org/10.1007/s40256-024-00706-9

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now
Video

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases